• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    InnoCare Announces Acceptance of NDA for Zurletrectinib in China

    BUSINESSWIRE

    Zurletrectinib Shows Strong Activity Against NTRK Fusion-Positive Tumors

    BUSINESSWIRE

    InnoCare Announces First Pediatric Patient Dosed in Trial of Zurletrectinib

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.